[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fXbyU536Ry8G7xMXG4ZuwIUiqR-vMRVBLEmIhlmbdxUc":8,"$fETADiOGgEUs6cIHlbaz77ITTjWzhGYcO_rNVmHDQKeM":55,"$fvI2QuppyExnKsxVXvUCu2vKU0qLl8Wv2ck0H94C_ANM":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},71873,867451,[],"https://ystcdn.venuertc.com/medical/ystApp/t0US13DNdGYbbVXINAX1q5n2vRwR8fnc.png","霍文捷","山西省人民医院","肿瘤科","主治医师",109,0,"浸润性导管癌：重要知识与应对策略","","https://ystcdn.venuertc.com/venue/AI/a488b3be-796d-4239-8283-8dbed7f6683c.jpg","\u003Cdiv class=\"dai_breast_material\">\n  \u003Ch1 id=\"material_title\" class=\"dai_breast_title\">浸润性导管癌：重要知识与应对策略\u003C/h1>\n  \u003Cdiv class=\"dai_breast_section dai_breast_section1\">\n    \u003Cdiv class=\"dai_breast_subtitle_bg\">\n      \u003Ch2 class=\"dai_breast_subtitle\">01 理解浸润性导管癌是什么\u003C/h2>\n    \u003C/div>\n    \u003Cdiv class=\"dai_breast_text\">\n      每天清晨，你或许会在洗漱或换衣时用手摸一摸乳房，顺便关注乳腺的健康状况——这其实很常见。浸润性导管癌就是在这种自我关注中，有时候会不知不觉出现的“隐形麻烦”，它是女性乳腺癌中最普遍类型，源自乳腺导管里的细胞出现异常，并逐步逐步扩展到周边组织。\n      \u003Cbr>\u003Cbr>\n      说起来，乳腺导管就像一条输送牛奶的小管道，浸润性导管癌的发生，就是这些管道里的细胞变得“不正常”，一开始很难察觉，但却在默改变乳腺内部环境。尤其对女性来说，乳腺健康关乎整个身体的活力和自信，一旦这些不正常的细胞持续发展，就可能影响到更大的组织甚至淋巴系统，对健康构成威胁。\u003Cspan class=\"dai_breast_emoji\">🩺\u003C/span>\n      \u003Cbr>\u003Cbr>\n      简单来讲，预防和关注浸润性导管癌，最关键的是及时了解它的基本特征，及早发现，才能争取处理的主动权。\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"dai_breast_section dai_breast_section2\">\n    \u003Cdiv class=\"dai_breast_subtitle_bg\">\n      \u003Ch2 class=\"dai_breast_subtitle\">02 如何识别浸润性导管癌的症状？\u003C/h2>\n    \u003C/div>\n    \u003Cdiv class=\"dai_breast_text\">\n      下面这一组信号，值得大家特别关注：\n      \u003Cul class=\"dai_breast_list\">\n        \u003Cli>\n          \u003Cspan class=\"dai_breast_highlight\">持续性乳腺肿块\u003C/span>：如果发现乳房内部有一个摸起来比较硬、轮廓清晰的肿块，并且这块肿块没有随着月经周期消退，那就要提高警惕。有时肿块伴随腋下淋巴结肿大，像是多了一颗小核桃，这种变化往是乳腺癌最典型的信号。\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan class=\"dai_breast_highlight\">乳头分泌物或异常出血\u003C/span>：有部分患者会注意到乳头无缘无故流出淡黄、粉色甚至带血的液体。尤其是单侧乳头持续分泌，或乳头区明显渗血，这类情况绝不能拖延。\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan class=\"dai_breast_highlight\">皮肤变化\u003C/span>：乳房皮肤出现不规则凹陷、橘皮样改变，或表面发红、变厚，都属于明显异常。“像橘子皮”这种变化，常见于癌症开始影响皮肤下层组织的时候。\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan class=\"dai_breast_highlight\">全身反应\u003C/span>：部分人可能还会伴随持续的恶心、呕吐，尤其是肿块影响到体内其他系统时。\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan class=\"dai_breast_highlight\">个案启示\u003Cspan class=\"dai_breast_emoji\">🔍\u003C/span>\u003C/span>：有一位41岁的女性，发现左乳肿块，腋下淋巴结肿大且溢血，最终确诊为浸润性导管癌（IIIA期）。这个例子提醒我们，一旦乳腺肿块和分泌物持续存在，千万不要犹豫，及时就医是最好的选择。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cbr>\n      不要等待所有症状都出现，有一点持续或严重的不正常，都是安全起见的理由。\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"dai_breast_section dai_breast_section3\">\n    \u003Cdiv class=\"dai_breast_subtitle_bg\">\n      \u003Ch2 class=\"dai_breast_subtitle\">03 致病机制分析：为什么会发生浸润性导管癌？\u003C/h2>\n    \u003C/div>\n    \u003Cdiv class=\"dai_breast_text\">\n      问到“为什么会长癌”，其实原因并不简单。医学界认为，浸润性导管癌的发生主要有以下几个方面：\n      \u003Cul class=\"dai_breast_list\">\n        \u003Cli>\n          \u003Cspan class=\"dai_breast_highlight\">遗传因素\u003C/span>：家族中如果有乳腺癌史，风险会增加。BRCA基因突变就是最具代表性的遗传因素。例如，一项研究指出，遗传易感性相关基因（如BRCA1/2变异）能显著提高乳腺癌发病概率。\u003Cspan class=\"dai_breast_emoji\">🧬\u003C/span>\n          \u003Cbr>\n          \u003Cspan class=\"dai_breast_reference\">(参考：Easton, D.F. et al., \"BRCA1 and BRCA2 gene mutations, breast cancer risks, and cancer prevention\", New England Journal of Medicine, 2007)\u003C/span>\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan class=\"dai_breast_highlight\">激素水平波动\u003C/span>：雌激素是乳腺细胞的重要“指挥棒”。如果长期暴露于较高雌激素水平，比如较晚绝经或过早初潮，乳腺癌的危险会明显增加。口服避孕药和激素替代治疗也有一定影响，但风险还需结合个人体质综合判断。\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan class=\"dai_breast_highlight\">年龄相关变化\u003C/span>：年龄是众多癌症的大背景因素。多数浸润性导管癌见于50岁以后人群，但也有像上面提到的41岁女性一样较早发生的情况。这说明年龄虽是风险，但不是唯一标准。\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan class=\"dai_breast_highlight\">生活方式和环境暴露\u003C/span>：长期高脂饮食、缺乏运动、过度饮酒，以及长期暴露于环境激素、放射线，都被列入危险因素。\u003Cbr>\n          研究报道，BMI过高、运动过少等生活习惯与乳腺癌发病之间有关联。（参考：Kroenke et al., \"Physical activity and breast cancer survival\", Journal of Clinical Oncology, 2004）\n        \u003C/li>\n      \u003C/ul>\n      这些风险看似离自己很远，但其实在日常生活中零星出现。提高认知、关注自身变化，对健康非常有帮助。\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"dai_breast_section dai_breast_section4\">\n    \u003Cdiv class=\"dai_breast_subtitle_bg\">\n      \u003Ch2 class=\"dai_breast_subtitle\">04 浸润性导管癌如何诊断？\u003C/h2>\n    \u003C/div>\n    \u003Cdiv class=\"dai_breast_text\">\n      发现乳腺异常，第一步并不是冷静观察，而是寻找专业诊断方法。常用的流程一般包括：\n      \u003Cul class=\"dai_breast_list\">\n        \u003Cli>\n          \u003Cspan class=\"dai_breast_highlight\">乳腺影像学检查\u003C/span>：首选乳腺钼靶（X线），有时候还会搭配彩超。通过成像能发现乳腺里的肿块、分布及大小。结合磁共振检查，可以进一步明确疑难位置和组织特点。\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan class=\"dai_breast_highlight\">组织活检\u003C/span>：在影像发现异常后，医生会用细针/粗针取出部分组织，送实验室分析。这样既确定是否癌症，也能分析癌细胞类型和分子特征（比如激素受体、HER-2状态等）。\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan class=\"dai_breast_highlight\">分期和风险评估\u003C/span>：借助图像和活检结果，医生会判断肿瘤分期（例如上面41岁女性案例中的IIIA期）、淋巴结转移情况、侵染范围，为后续治疗方案定下基础。\n        \u003C/li>\n      \u003C/ul>\n      总之，诊断流程越规范，后面的处理越有针对性。而不是依赖单一方式。事实证明，结合多种检查手段，能最大程度减少误诊（参考：Bergen et al., \"Pathologic staging of breast cancer\", Current Oncology Reports, 2021）。\n      \u003Cbr>\n      如果你自己摸到乳腺肿块持续不消，或发现乳头异常分泌，预约乳腺专科医生进行影像与活检，是最合理的做法。\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"dai_breast_section dai_breast_section5\">\n    \u003Cdiv class=\"dai_breast_subtitle_bg\">\n      \u003Ch2 class=\"dai_breast_subtitle\">05 治疗浸润性导管癌，有哪些选择？\u003C/h2>\n    \u003C/div>\n    \u003Cdiv class=\"dai_breast_text\">\n      很多人提到癌症，总会联想到复杂的治疗方案和副作用。其实浸润性导管癌的治疗已非常标准化，常见方式分三类：\n      \u003Col class=\"dai_breast_list\">\n        \u003Cli>\n          \u003Cspan class=\"dai_breast_highlight\">手术治疗\u003C/span>：绝大多数早期或局限型患者会首选乳房手术，分为保乳手术（只去掉肿块，保留部分乳腺）或乳房全切。手术不仅去除肿瘤，还能降低复发率。是否选择保乳，需要医生评估肿块大小、位置、淋巴结状态等。（参考：Fisher et al., \"Ten-year results of a randomized clinical trial comparing mastectomy and segmental mastectomy with or without radiation\", New England Journal of Medicine, 1989）\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan class=\"dai_breast_highlight\">化学药物治疗\u003C/span>\u003Cspan class=\"dai_breast_emoji\">💊\u003C/span>：针对肿瘤分子特征（如HER-2阳性、ER/PR状态），选择特定药物治疗。例如，紫杉醇类药物广泛应用于辅助化疗，用于控制肿瘤发展、减少术后复发。配合止吐、护胃、护肝支持，能显著改善副作用。对某些人群来说，靶向药物（如针对HER-2）还能提高治疗效果。\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan class=\"dai_breast_highlight\">放射治疗\u003C/span>：特别是在乳房局切后，通过局部放疗，可以消灭残余的癌细胞，进一步降低复发风险。\n        \u003C/li>\n      \u003C/ol>\n      治疗方案绝不是“固定搭配”，而是根据患者年龄、分期、分子特征、耐受性等具体因素决定。比如上文案例中，采用紫杉醇类药物进行静脉化疗，配合对症支持，就是个体化选择的体现。\n      \u003Cbr>\n      一句话概括：选对方案，积极配合，才能实现效果最大化。\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"dai_breast_section dai_breast_section6\">\n    \u003Cdiv class=\"dai_breast_subtitle_bg\">\n      \u003Ch2 class=\"dai_breast_subtitle\">06 如何管理日常乳腺健康？\u003C/h2>\n    \u003C/div>\n    \u003Cdiv class=\"dai_breast_text\">\n      很多乳腺癌患者都会问：“生活中我能做什么？”其实良好的乳腺管理，将健康主动权掌握在自己手里：\n      \u003Cul class=\"dai_breast_list\">\n        \u003Cli>\n          \u003Cspan class=\"dai_breast_highlight\">均衡饮食\u003C/span>：多吃高纤维蔬菜（比如西兰花、菠菜等），有助调节体内雌激素水平；每天保证适量乳制品有助骨骼健康；优质蛋白如豆制品能补充基础营养。\n          \u003Cbr>\n          \u003Cspan class=\"dai_breast_reference\">(Rock et al., \"Diet, physical activity, and breast cancer\", CA: A Cancer Journal for Clinicians, 2020)\u003C/span>\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan class=\"dai_breast_highlight\">坚持运动\u003C/span>：慢跑、快走、游泳都是好选择，能降低肥胖带来的激素波动。成年人每周150分钟中等强度运动，效果最优。\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan class=\"dai_breast_highlight\">自我乳腺检查\u003C/span>：每月一次自检，月经结束后数天为最佳时机。用指腹仔细按压乳腺各个区域，体会有无新生肿块、皮肤凹陷或者异常分泌。如果摸到“不对劲”的地方，记得及时到乳腺专科门诊检查。\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan class=\"dai_breast_highlight\">定期体检\u003C/span>：40岁以后，建议每2年做一次乳腺影像学检查。即使没有明显症状，也要有防患于未然的意识，把健康掌握在自己手里。\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan class=\"dai_breast_highlight\">压力管理与心理支持\u003C/span>：保持平和心态，和家人朋友多沟通，有利于整体健康；加入患者互助群也可以获得更多经验和力量。\n        \u003C/li>\n      \u003C/ul>\n      说到底，乳腺是女性身体里的“小卫士”，精心呵护，让它保持稳定，才能远离不速之客。\u003Cspan class=\"dai_breast_emoji\">🍃\u003C/span>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"dai_breast_section dai_breast_section7\">\n    \u003Cdiv class=\"dai_breast_subtitle_bg\">\n      \u003Ch2 class=\"dai_breast_subtitle\">07 总结与行动建议\u003C/h2>\n    \u003C/div>\n    \u003Cdiv class=\"dai_breast_text\">\n      简单来说，浸润性导管癌虽然是乳腺癌的常见类型，但只要早发现、早诊断、科学治疗，绝大部分患者都能获得良好疗效。每位女性都值得成为自己健康的“守门人”，无论遇到何种变化，都不要慌张。在日常生活中，管理好饮食、坚持运动、做好自检，就是最实用的预防策略。如果真的出现持续肿块或分泌异常，及时寻找专业医生，比拖延要更安全更明智。\n      \u003Cbr>\u003Cbr>\n      最后，乳腺健康是“用心呵护”得来的。关注自身、主动检查、科学行动，就是给自己和家人最好的礼物。\n      \u003Cbr>\u003Cbr>\n      \u003Cspan class=\"dai_breast_emoji\">👩‍⚕️\u003C/span> 保持积极心态！有任何疑虑，向乳腺专科医生或者身边的健康专业人士寻求帮助，是通往安心的第一步。\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"dai_breast_section dai_breast_section8\">\n    \u003Cdiv class=\"dai_breast_subtitle_bg\">\n      \u003Ch2 class=\"dai_breast_subtitle\">参考文献与扩展阅读\u003C/h2>\n    \u003C/div>\n    \u003Cdiv class=\"dai_breast_references\">\n      \u003Cul>\n        \u003Cli>Easton, D.F., et al. (2007). BRCA1 and BRCA2 gene mutations, breast cancer risks, and cancer prevention. \u003Ci>New England Journal of Medicine\u003C/i>.\u003C/li>\n        \u003Cli>Kroenke, C.H., et al. (2004). Physical activity and breast cancer survival. \u003Ci>Journal of Clinical Oncology\u003C/i>.\u003C/li>\n        \u003Cli>Bergen, S. et al. (2021). Pathologic staging of breast cancer. \u003Ci>Current Oncology Reports\u003C/i>.\u003C/li>\n        \u003Cli>Fisher, B., et al. (1989). Ten-year results of a randomized clinical trial comparing mastectomy and segmental mastectomy with or without radiation. \u003Ci>New England Journal of Medicine\u003C/i>.\u003C/li>\n        \u003Cli>Rock, C.L., et al. (2020). Diet, physical activity, and breast cancer. \u003Ci>CA: A Cancer Journal for Clinicians\u003C/i>.\u003C/li>\n      \u003C/ul>\n    \u003C/div>\n  \u003C/div>\n\u003C/div>\n\u003Cstyle>\n.dai_breast_material {\n  font-family: \"Segoe UI\", \"Arial\", \"sans-serif\";\n  background: #f8f9fa;\n  color: #232323;\n  max-width: 780px;\n  margin: 0 auto;\n  padding: 36px 36px 64px 36px;\n  box-shadow: 0 0 12px #e5e5e5;\n  border-radius: 18px;\n}\n.dai_breast_title {\n  background: linear-gradient(90deg, #e9b7ce 0%, #b7d1e9 100%);\n  font-size: 36px;\n  text-align: center;\n  padding: 32px 0 25px 0;\n  border-radius: 12px;\n  letter-spacing: 2px;\n}\n\n.dai_breast_subtitle {\n  font-size: 25px;\n  margin: 0;\n  padding: 0 0 10px 0;\n  color: #4a4a64;\n  font-weight: 600;\n  letter-spacing: 1px;\n}\n.dai_breast_subtitle_bg {\n  margin-bottom: 0px;\n  padding: 24px 0 20px 0;\n  background: linear-gradient(87deg, #e1ebe1 0%, #f5e7ef 100%);\n  border-radius: 8px 8px 8px 8px;\n  box-shadow: 0 2px 9px #ededed inset;\n}\n.dai_breast_text {\n  font-size: 18px;\n  line-height: 1.92;\n  padding: 18px 10px 12px 10px;\n  margin-bottom: 6px;\n  background: #fbfc;\n  border-radius: 7px;\n  box-shadow: 0 2px 10px #f0f0f8;\n}\n.dai_breast_list {\n  margin: 16px 0 16px 18px;\n  padding: 0 0 0 6px;\n  font-size: 18px;\n  line-height: 1.85;\n}\n.dai_breast_highlight {\n  color: #ad2676;\n  font-weight: 600;\n}\n.dai_breast_reference {\n  color: #5a8aa5;\n  font-size: 16px;\n  font-style: italic;\n}\n.dai_breast_emoji {\n  font-size: 22px;\n  vertical-align: middle;\n  margin-left: 5px;\n}\n.dai_breast_references {\n  background: #f2f4fa;\n  border-radius: 9px;\n  padding: 19px 24px;\n  font-size: 17px;\n  color: #2a2a4a;\n  margin-top: 10px;\n  box-shadow: 0 1px 7px #e7e7f4;\n}\n.dai_breast_section { margin-bottom: 32px; }\n@media (max-width: 900px) {\n  .dai_breast_material { padding: 18px 6vw 54px 6vw; }\n  .dai_breast_title { font-size: 28px; }\n  .dai_breast_subtitle { font-size: 21px; }\n  .dai_breast_text, .dai_breast_list { font-size: 16px; }\n  .dai_breast_reference { font-size: 15px; }\n  .dai_breast_references { font-size: 15px; }\n}\n\u003C/style>","\u003Cdiv class=\"dai_breast_material\">\n  \u003Ch1 id=\"material_title\" class=\"dai_breast_title\">浸润性导管癌：重要知识与应对策",514,"2025-11-11 00:28:32","浸润性导管癌, 乳腺癌症状, 乳腺健康管理, 乳腺影像学检查, 乳腺治疗选择, 女性健康, 自查方法, 早期诊断","了解浸润性导管癌的症状、致病机制和治疗选择，掌握乳腺健康管理方法，早发现早治疗，保护女性健康。","2025-11-18 14:18:04",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]